Jay Lee

Jay Lee is a senior equity analyst, AM Healthcare, for Morningstar*. He covers Life Science Tools and Diagnostics companies as well as large Japanese drugmakers, including Sartorius AG, West Pharmaceuticals, Exact Sciences, Guardant Health, Bio-Techne, Daiichi Sankyo, and Chugai Pharmaceuticals.

Before joining Morningstar in 2017, Lee was an executive director and Asia head of mortgage products at Goldman Sachs, where he spent 11 years working on trading desks in New York, Tokyo, and Hong Kong. At Morningstar, he spent five years in Hong Kong covering Chinese and Japanese healthcare companies, including large drugmakers, biotech companies, and contract development and manufacturing organizations, before transferring to his current role in Chicago.

Lee holds a bachelor’s degree in mathematics from Brown University.

* Morningstar Research Services LLC (“Morningstar”) is a wholly owned subsidiary of Morningstar, Inc